Targeted Cell Therapies is an early-stage Massachusetts-based biopharmaceutical company that is using its powerful technology platform for the development of biotherapeutics for a broad range of human diseases. Targeted Cell Therapies technology permits the oral delivery of large molecules, avoiding the usual need for injection.